RRM2 and familial pancreatic carcinoma: Itoi et al examined RRM2 mRNA levels in biopsy specimens from 35 patients with unresectable pancreatic cancer in a prospective study, and found that the response rate to gemcitabine chemotherapy was significantly higher in patients with low RRM2 expression[26].